description AbbVie (ABBV) Overview
AbbVie Inc. (ABBV) is a global biopharmaceutical company primarily focused on developing and commercializing therapies for immunology, oncology, neuroscience, eye care, and virology, generating revenue through sales of blockbuster drugs like Humira and Skyrizi.
help AbbVie (ABBV) FAQ
What is AbbVie (ABBV)?
AbbVie Inc. (ABBV) is a global biopharmaceutical company primarily focused on developing and commercializing therapies for immunology, oncology, neuroscience, eye care, and virology, generating revenue through sales of blockbuster drugs like Humira and Skyrizi.
How good is AbbVie (ABBV)?
AbbVie (ABBV) scores 8.18/10 (Great) on Lunoo, making it a well-rated option in the Dividend Stock category.
What are the best alternatives to AbbVie (ABBV)?
See our alternatives page for AbbVie (ABBV) for a ranked list with scores. Top alternatives include: Pfizer (PFE), Chevron (CVX), Exxon Mobil (XOM).
How does AbbVie (ABBV) compare to Pfizer (PFE)?
See our detailed comparison of AbbVie (ABBV) vs Pfizer (PFE) with scores, features, and an AI-powered verdict.
Is AbbVie (ABBV) worth it in 2026?
With a score of 8.18/10, AbbVie (ABBV) is highly rated in Dividend Stock. See all Dividend Stock ranked.
explore Explore More
Similar to AbbVie (ABBV)
See all arrow_forward
Reviews & Comments
Write a Review
Be the first to review
Share your thoughts with the community and help others make better decisions.
